Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tehran Darou Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer founded in 1950, dedicated to the production of high-quality generic medicines. The company offers an extensive portfolio of over 100 products across various therapeutic categories, including cardiovascular, central nervous system, gastrointestinal, and respiratory health. Operating out of its manufacturing complex in Tehran, the firm adheres to international Good Manufacturing Practice (GMP) standards to ensure product safety and efficacy. Tehran Darou serves both the domestic Iranian healthcare system and international markets through strategic exports. The company is publicly traded on the Tehran Stock Exchange and continues to expand its production lines to include advanced formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tehran Darou.